October 27, 2016
CTI Clinical Trial & Consulting Services Presented in Keynote Session at Intacct 2016 Advantage Conference
FOR IMMEDIATE RELEASE [Cincinnati, OH ~ October 27, 2016]
CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, presented at the Intacct 2016 Advantage Conference. CTI’s Senior Manager of Taxation and Financial Planning/Analysis, Brian Lawrence, CPA, spoke as part of the Keynote Session Customer Panel on Thursday morning.
“I am very excited to be a part of this keynote session,” according to Lawrence. “Intacct has helped CTI manage our international budgets, time tracking, and accounts payable in a time-saving capacity, and we're happy to share our success story with others.”
Lawrence has been with CTI for several years and has been integral to the growth and development of the company, including spearheading the system implementation of Intacct and serving on the selection committee for CTI's headquarter search. He currently manages all of the company's international taxation and financial planning. Prior to joining CTI, Lawrence spent nearly a decade working in tax with Clark Schaefer Hackett.
About Intacct Advantage 2016
Advantage 2016 is the must-attend event for Intacct customers and partners. From introductory workshops to advanced training, a full range of sessions are available to customize your conference experience. In addition, attendees can access direct support from Intacct experts, explore the Marketplace Expo to learn about partner solutions or services, and network with peers to share best practices or just unwind after a productive day. Optional pre-conference training courses are also available at an additional cost for more in-depth education.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com